Francois Vigneault, departing Shape Therapeutics CEO
October 17, 2024 01:16 PM EDT
People
Startups
Cell/Gene Tx

RNA gene ther­a­py start­up Shape hunts for new CEO as Se­ries C awaits

Kyle LaHucik

Senior Reporter

Shape Ther­a­peu­tics CEO Fran­cois Vi­gneault has de­part­ed the RNA gene ther­a­py start­up, and chief sci­en­tif­ic of­fi­cer David Huss is fill­ing the post while the Seat­tle …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA ap­proves Ab­b­Vie's 24-hour Parkin­son's in­fu­sion ther­a­py af­ter two CRLs

Se­cre­tive Tree­line Bio­sciences dis­clos­es $421M fi­nanc­ing in fil­ing

Benev­o­len­tAI CEO is out af­ter less than a year on the job

Sage shakes up se­nior man­age­ment, slash­es pipeline, sheds 33% of staff

No­var­tis pays $70M up­front to li­cense Chi­nese biotech’s an­ti­tu­mor drug

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times